Bristol-Myers Squibb Co (NYSE: BMY) is 4.65% higher on its value in year-to-date trading and has touched a low of $39.35 and a high of $63.33 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BMY stock was last observed hovering at around $61.05 in the last trading session, with the day’s loss setting it -1.86%.
Currently trading at $59.19, the stock is -1.48% and 1.41% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.96 million and changing -3.05% at the moment leaves the stock 12.70% off its SMA200. BMY registered 14.73% gain for a year compared to 6-month gain of 19.79%. The firm has a 50-day simple moving average (SMA 50) of $58.368 and a 200-day simple moving average (SMA200) of $52.5209.
The stock witnessed a 2.26% loss in the last 1 month and extending the period to 3 months gives it a 5.13%, and is -1.19% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.51% over the week and 2.60% over the month.
Bristol-Myers Squibb Co (BMY) has around 34100 employees, a market worth around $120.11B and $48.30B in sales. Fwd P/E is 9.67. Profit margin for the company is -18.53%. Distance from 52-week low is 50.42% and -6.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.70%).
The EPS is expected to grow by 486.12% this year.
Bristol-Myers Squibb Co (BMY) Top Institutional Holders
3128.0 institutions hold shares in Bristol-Myers Squibb Co (BMY), with institutional investors hold 80.93% of the company’s shares. The shares outstanding are 2.03B, and float is at 2.03B with Short Float at 1.51%. Institutions hold 80.85% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 186.57 million shares valued at $7.75 billion. The investor’s holdings represent 9.2225% of the BMY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 158.66 million shares valued at $6.59 billion to account for 7.8273 of the shares outstanding. The other top investors are STATE STREET CORP which holds 91.45 million shares representing 4.5114% and valued at over $3.8 billion, while JPMORGAN CHASE & CO holds 3.6818 of the shares totaling 74.63 million with a market value of $3.1 billion.
Bristol-Myers Squibb Co (BMY) Insider Activity
The most recent transaction is an insider purchase by BOERNER CHRISTOPHER S., the company’s Chief Executive Officer. SEC filings show that BOERNER CHRISTOPHER S. bought 2,000 shares of the company’s common stock on Feb 20 ’25 at a price of $55.05 per share for a total of $0.11 million. Following the purchase, the insider now owns 0.1 million shares.
Bristol-Myers Squibb Co disclosed in a document filed with the SEC on Feb 14 ’25 that Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) bought a total of 1,823 shares of the company’s common stock. The trade occurred on Feb 14 ’25 and was made at $54.84 per share for $100000.0. Following the transaction, the insider now directly holds 63932.0 shares of the BMY stock.
Still, SEC filings show that on Nov 04 ’24, Holzer Phil M (SVP and Controller) disposed off 700 shares at an average price of $55.62 for $38930.0. The insider now directly holds 11,760 shares of Bristol-Myers Squibb Co (BMY).
